References
- US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance For Industry, Labeling Guidance for Noncontraceptive Estrogen Drug Products for the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms – Prescribing Information for Health Care Providers and Patient Labeling. February 2004, Revision 1, at http://www.fda.gov/cder/guidance/5670dft.pdf
- Birkhäuser MH, Panay N, Archer DF, et al Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008;11:108–123
- NAMS: Estrogen and progestogen use in postmenopausal women. Menopause 2008;5:584–602
- 2007 position statement of The North American Menopause Society: The role of local vaginal estrogen for treatment of vaginal atrophy. Menopause 2007;14:355–356
- Skouby SO, Al-Azzawi F, Barlow D, et al Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas 2005;51:8–14
- Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Obstet Gynecol 2008;112:1053–1060
- Santen RJ, Demers L, Ohorodnik S, et al Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids 2007;72:666–671
- Stanczyk FK, Lee JS, Santen RJ. Standardisation of steroid hormone assays: why, how and when? Cancer Epidemiol Biomarkers Prev 2007;16:1713–1719
- Nilsson K, Heimer G. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency – a pharmacokinetic and pharmacodynamic study. Maturitas 1992;15:121–127
- Rossin-Amar B. Vaginal dryness in the menopausal women (physiological and psychological aspects). Gynecol Obstet Fertil 2000;28:245–249
- Wang S, Paris F, Sultan CS, et al Recombinant cell ultrasensitive bioassay for measurement of estrogens in postmenopausal women. J Clin Endocrinol Metab 2005;90:1407–1413
- Tourgeman DE, Gentzchein E, Stanczyk FZ, Paulson RJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Obstet Gynecol 1999;180:1480–1483